Curaleaf International, part of Curaleaf Holdings (TSX:CURA) and one of Europe’s largest vertically integrated cannabis companies, is expanding into the
The birth of a vertically integrated, EU GMP, Clean Green(R) certified organic, global medical cannabis company with a unique and
SOMAÍ Pharmaceuticals Signs Distribution Deal with Grow Pharma for UK’s Most Comprehensive Range of Cannabis-Based Medicines SOMAÍ Pharmaceuticals (“SOMAÍ”), an
Embattled Canadian cannabis producer BZAM Group has successfully secured Companies’ Creditors Arrangement Act (CCAA) protection, allowing it to stave off
SOMAÍ Pharmaceuticals Unipessoal LDA (“SOMAÍ”), an EU-GMP European pharmaceutical and biotech company distributing cannabinoid-containing pharmaceuticals globally, today announced it has
From 26th February, the medical cannabis division of Rokshaw Ltd is rebranding to Curaleaf Laboratories. Since its inception in 2012
Two more New York cannabis dispensaries have been granted the green light to open their doors as the state continues
UK medical cannabis cultivator Glass Pharms has officially completed the construction of its 2.4 hectare ‘state-of-the-art’ carbon negative cultivation facility
Canadian cannabis giant Aurora yesterday announced plans to enact a 1:10 stock consolidation in order to avoid delisting from the
Canadian cannabis giant Canopy Growth announced plans to launch a new $35 million private fundraise as it continues efforts to
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.